by Elanco France S.A.S.
Atopica Capsules is supplied by Elanco France S.A.S. under product code A-12217 A; ATOPICA 100 MG (CYCLOSP.CAPS.USP) MOD; Atopica 100 Mg Cap; ATOPICA 100 MG SOFT CAPSULES FOR DOGS; ATOPICA VET. 100 MG CAP; ATOPLUS 100 MG CAP; CA4902; CGA116231 CAP (100); NEORAL 100 MG CAP; A-12214 A; ATOPICA 10 MG (CYCLOSP.CAPS.USP) MOD; Atopica 10 Mg Cap; ATOPICA 10 MG SOFT CAPSULES FOR DOGS; ATOPICA VET. 10 MG CAP; ATOPLUS 10 MG CAP; CA4915; CGA116231 CAP (010); NEORAL 10 MG CAP; A-12215 A; ATOPICA 25 MG (CYCLOSP.CAPS.USP) MOD; Atopica 25 Mg Cap; ATOPICA 25 MG SOFT CAPSULES FOR DOGS; ATOPICA VET. 25 MG CAP; ATOPLUS 25 MG CAP; CA4910; CGA116231 CAP (025); NEORAL 25 MG CAP; A-12216 A; ATOPICA 50 MG (CYCLOSP.CAPS.USP) MOD; Atopica 50 Mg Cap; ATOPICA 50 MG SOFT CAPSULES FOR DOGS; ATOPICA VET. 50 MG CAP; ATOPLUS 50 MG CAP; CA4905; CGA116231 CAP (050); NEORAL 50 MG CAP. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.
This SDS was last revised on 6 March 2023. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.
Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.
GHS02Flammable
GHS08Health hazardNeed the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.




















Need to download the Chemical Risk Assessment? The full CRA PDF includes all hazard classifications, regulatory statements and recommended controls.